Table:
begin	end	state
1	46	cytoplasmic
47	66	transmembrane
67	71	non-cytoplasmic
72	96	transmembrane
97	107	cytoplasmic
108	127	transmembrane
128	131	non-cytoplasmic
132	160	transmembrane
161	172	cytoplasmic
173	195	transmembrane
196	206	non-cytoplasmic
207	228	transmembrane
229	258	cytoplasmic
259	281	transmembrane
282	295	non-cytoplasmic
296	318	transmembrane
319	326	cytoplasmic
327	345	transmembrane
346	353	non-cytoplasmic
354	374	transmembrane
375	386	cytoplasmic
387	409	transmembrane
410	411	non-cytoplasmic
412	413	transmembrane
414	414	non-cytoplasmic
415	435	transmembrane
436	446	cytoplasmic

Input:
>CCNA_01852
MASELAIPKSSGLERDARRMHADDKGVRPGEIALGVVIGRTSEFFDFFVYAIASVLVFPQ
LVFPFVDRLTGVMLAFGLFALAFIARPFGSVIFGAIDQRYGRGVKLTIALFLLGGSTAVI
SMLPSFAAVGPIAIWALAACRIGQGLALAGAWDGMASLLALNAPENKRGWYAMIPQLGAP
FGFMLASGLFAYFVATLAPADFLDWGWRYPFFAAFAINVVALFARLRIVATEEFGALFEK
RELRPTRVASLLRAEGGNVLIGAFAPLATFAMFHLVTVFPLSWVVLHGDAQQALNFLRIE
LFGALVGVGGILASGWIADRITRQNQLALSALLIGAFSLLAPRLLDGGATGQTAYVVIGF
AILGLSFGQAAGAVSSGFSKRYRYTGAALTSDLSWLIGAGFAPLAALGLASLWGLPAIGL
YLASGALATLLALTIDRTRRRRQAHC

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server